Dow Chemical gave Third Point two board seats — then agreed to merge with DuPont

In January 2014 Third Point, Daniel Loeb's hedge fund, disclosed that Dow Chemical was its largest investment, a 2.3% stake. Loeb argued that Dow's integrated model — commodity chemicals fused with specialties — buried its earnings under overhead and that shareholders would be better served by a breakup. Dow CEO Andrew Liveris spent the year defending integration, including at a November investor forum.

The fight turned hostile that month when Third Point launched value-dow.com, a website mocking Dow's 'excuses', and named two prospective board nominees: AIG chairman R. Steven Miller and former Foster Wheeler CEO Raymond Milchovich. Rather than face a proxy contest, Dow settled within days: on November 20, 2014 it agreed to add Miller and Milchovich plus two directors of its own choosing — U.S. Bancorp CEO Richard Davis and former IBM CFO Mark Loughridge — effective January 2015, in exchange for a one-year standstill. Third Point took down the attack site.

The truce did not save the integrated model. In December 2015 Dow agreed to merge with DuPont and split the combined company into three focused businesses — agriculture, materials and specialties — a structure much closer to Loeb's breakup thesis than to Liveris's defense.

Dow avoided a proxy war, added four directors, and within a year struck the Dow-DuPont merger and planned three-way split Loeb's breakup logic anticipated.

Loeb's comparison of Dow's returns to the S&P 500 Chemicals Index gave the campaign a simple, credible metric.

The attack website and named nominees made a proxy contest imminent and credible.

Dow chose settlement over a fight it might lose, gaining a year of peace and two directors of its own.

Once breakup logic was normalized inside the boardroom, the Dow-DuPont merger became negotiable.

An activist does not need to win the vote to win the argument: a credible public campaign can push an integrated giant toward the breakup it was built to resist.

The DowDuPont merger closed in August 2017 and the company split into Dow, DuPont and Corteva by 2019. Liveris left in 2018. Third Point had long since moved on, its breakup thesis effectively adopted by the industry it had targeted.